Pseudomonas aeruginosa in cystic fibrosis: pathogenesis and persistence
1Department of Gene Therapy, Imperial College School of Medicine, London, UK.
Abstract:
Pseudomonas aeruginosa is the major pathogen in the cystic fibrosis (CF) lung. Prevalence is high and, once acquired, chronic infection will almost always ensue. Several hypotheses related to the underlying molecular defects in CF have been suggested to explain this high rate of prevalence. These include abnormalities of airway surface liquid leading to impaired mucociliary clearance or malfunction of antibacterial peptides, increased availability of bacterial receptors, reduced ingestion of pathogens by CF cells and impaired defence related to low levels of molecules such as nitric oxide or glutathione. Further work is needed to identify which of these mechanisms is important in the early stages of infection. Once the organisms have gained a foothold in the CF airway they have a wide array of properties that enhance their survival and allow them to evade host defences and antibiotic agents successfully. Conversion to mucoidy and the formation of biofilms are two of the main mechanisms by which this is achieved. Understanding the steps involved in both initial infection and in establishing chronicity may help in the development of new treatment strategies.
Insights
Pseudomonas aeruginosa frequently causes chronic lung infections in cystic fibrosis (CF) patients. Understanding early infection and chronicity mechanisms is crucial for developing new CF treatment strategies.
Area of Science:
- Medical Microbiology
- Pulmonology
- Genetics
Background:
- Pseudomonas aeruginosa is a primary pathogen in cystic fibrosis (CF) lungs, leading to high prevalence and chronic infections.
- The exact reasons for high P. aeruginosa prevalence in CF are unclear, with hypotheses including impaired airway defenses and increased bacterial receptor availability.
Purpose of the Study:
- To explore the molecular mechanisms behind P. aeruginosa colonization and persistence in the CF lung.
- To identify key factors contributing to the establishment and chronicity of P. aeruginosa infections in CF patients.
Main Methods:
- Review of existing hypotheses on CF-related molecular defects influencing P. aeruginosa infection.
- Analysis of bacterial adaptation strategies like mucoidy and biofilm formation.
Main Results:
- Several potential mechanisms for high P. aeruginosa prevalence in CF are proposed, including airway surface liquid abnormalities, impaired antibacterial peptides, and reduced phagocytosis.
- Mucoidy conversion and biofilm formation are identified as key bacterial strategies for survival and evasion of host defenses and antibiotics.
Conclusions:
- Further research is needed to pinpoint the specific early-stage infection mechanisms in CF.
- Understanding initial infection and chronicity pathways is essential for developing novel therapeutic strategies against P. aeruginosa in CF.
Related Concept Videos
01:23Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
01:30Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
01:28Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
01:29Microbiota of the Respiratory Tract
01:14Atypical Pneumonia
01:29Pneumonia I: Introduction